Sciele/LifeCycle’s “Meltdose” Fenofibrate Clears FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Sciele will launch fenofibrate formulation in 40 mg and 120 mg strengths for hyperlipidemia and hypertriglyceridemia by the end of 2007.